WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Site License Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

HistoRx, Inc. - Product Pipeline Analysis

GlobalData, November 2012, Pages: 39

Summary

HistoRx, Inc. (HistoRx) is a biopharmaceutical company based in the US. It operates through its service segments, pharmaceutical and research services. The company provides a solution to the need for quantitative, standardized and reproducible analysis of protein biomarkers in tissue. Its proprietary AQUA technology is used to develop a line of novel multi-marker tissue-based cancer diagnostics that will help precise measurement of critical, localized proteins. The technology of HistoRx is used by pharmaceutical companies and academic researchers in drug discovery and clinical development to gain new insights into cancer treatment. The pharmaceutical services provided by the company include, biomarker assay development, drug target validation, pharmacodynamic measurement, animal model validation, clinical tumor cohort studies, custom tissue microarray construction and analysis from retrospective and clinical trial samples and development of companion diagnostics. HistoRx is headquartered in Branford, Connecticut, the US.

This report is a source for data, analysis and actionable intelligence on the HistoRx, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

List of Tables
List of Figures
Key Facts
HistoRx, Inc. - Major Products and Services
HistoRx, Inc. Pipeline Products by Equipment Type
HistoRx, Inc. Pipeline Products by Development Stage
HistoRx, Inc. Pipeline Products by Therapy Area
Epidermal Growth Factor Receptor Assay - Breast Cancer
Epidermal Growth Factor Receptor Assay - Breast Cancer Product Status
Epidermal Growth Factor Receptor Assay - Breast Cancer Product Description
Epidermal Growth Factor Receptor Assay - Breast Cancer Product Patent Details
Epidermal Growth Factor Receptor Assay - Colon Cancer
Epidermal Growth Factor Receptor Assay - Colon Cancer Product Status
Epidermal Growth Factor Receptor Assay - Colon Cancer Product Description
Epidermal Growth Factor Receptor Assay - Colon Cancer Product Patent Details
Estrogen Receptor Assay
Estrogen Receptor Assay Product Status
Estrogen Receptor Assay Product Description
Estrogen Receptor Assay Product Patent Details
HER2 Receptor Assay
HER2 Receptor Assay Product Status
HER2 Receptor Assay Product Description
HER2 Receptor Assay Product Patent Details
PI3K Multimarker Assay
PI3K Multimarker Assay Product Status
PI3K Multimarker Assay Product Description
PI3K Multimarker Assay Product Patent Details
Progesterone Receptor Assay
Progesterone Receptor Assay Product Status
Progesterone Receptor Assay Product Description
Progesterone Receptor Assay Product Patent Details
SRC Multimarker Assay
SRC Multimarker Assay Product Status
SRC Multimarker Assay Product Description
SRC Multimarker Assay Product Patent Details
Thymidylate Synthase Assay
Thymidylate Synthase Assay Product Status
Thymidylate Synthase Assay Product Description
Thymidylate Synthase Assay Product Patent Details
HistoRx, Inc. - Key Competitors
HistoRx, Inc. - Key Employees
HistoRx, Inc. - Locations And Subsidiaries
Head Office
Recent Developments
HistoRx, Inc., Recent Developments
May 21, 2012: HistoRx Announces Application Of AQUA Technology To Assessment Of Messenger RNA In Tissue
Feb 28, 2012: HistoRx Secures Two Additional Patents On Standardization Of Results From Digital Pathology Instruments
Feb 21, 2012: HistoRx Earns Patent On Quantitative Immunoassay Optimization
Oct 07, 2011: HistoRx Receives Two Additional Patents On Standardization Of Results From Digital Pathology Instruments
Mar 21, 2011: Historx Receives Fundamental Patent On Standardization Of Results In Digital Pathology
Appendix
Methodology
About Us
Contact Us
Disclaimer

List of Tables
HistoRx, Inc., Key Facts
HistoRx, Inc. Key Pipeline Products by Equipment Type
HistoRx, Inc. Key Pipeline Products by Therapy Area
HistoRx, Inc. Key Pipeline Products by Development Stage
HistoRx, Inc., Key Facts
HistoRx, Inc., Major Products and Services
HistoRx, Inc. Number of Pipeline Products by Equipment Type
HistoRx, Inc. Pipeline Products by Equipment Type
HistoRx, Inc. Number of Pipeline Products by Development Stage
HistoRx, Inc. Pipeline Products by Development Stage
HistoRx, Inc. Number of Pipeline Products by Therapy Area
HistoRx, Inc. Pipeline Products by Therapy Area
Epidermal Growth Factor Receptor Assay - Breast Cancer - Product Status
Epidermal Growth Factor Receptor Assay - Breast Cancer - Product Description
Epidermal Growth Factor Receptor Assay - Breast Cancer - Patent Details1
Epidermal Growth Factor Receptor Assay - Breast Cancer - Patent Details2
Epidermal Growth Factor Receptor Assay - Breast Cancer - Patent Details3
Epidermal Growth Factor Receptor Assay - Breast Cancer - Patent Details4
Epidermal Growth Factor Receptor Assay - Breast Cancer - Patent Details5
Epidermal Growth Factor Receptor Assay - Breast Cancer - Patent Details6
Epidermal Growth Factor Receptor Assay - Breast Cancer - Patent Details7
Epidermal Growth Factor Receptor Assay - Breast Cancer - Patent Details8
Epidermal Growth Factor Receptor Assay - Colon Cancer - Product Status
Epidermal Growth Factor Receptor Assay - Colon Cancer - Product Description
Epidermal Growth Factor Receptor Assay - Colon Cancer - Patent Details1
Epidermal Growth Factor Receptor Assay - Colon Cancer - Patent Details2
Estrogen Receptor Assay - Product Status
Estrogen Receptor Assay - Product Description
Estrogen Receptor Assay - Patent Details1
Estrogen Receptor Assay - Patent Details2
HER2 Receptor Assay - Product Status
HER2 Receptor Assay - Product Description
HER2 Receptor Assay - Patent Details1
HER2 Receptor Assay - Patent Details2
PI3K Multimarker Assay - Product Status
PI3K Multimarker Assay - Product Description
PI3K Multimarker Assay - Patent Details1
PI3K Multimarker Assay - Patent Details2
Progesterone Receptor Assay - Product Status
Progesterone Receptor Assay - Product Description
Progesterone Receptor Assay - Patent Details1
Progesterone Receptor Assay - Patent Details2
SRC Multimarker Assay - Product Status
SRC Multimarker Assay - Product Description
SRC Multimarker Assay - Patent Details1
SRC Multimarker Assay - Patent Details2
Thymidylate Synthase Assay - Product Status
Thymidylate Synthase Assay - Product Description
Thymidylate Synthase Assay - Patent Details1
Thymidylate Synthase Assay - Patent Details2
HistoRx, Inc., Key Employees

List of Figures
HistoRx, Inc. Key Pipeline Products by Equipment Type
HistoRx, Inc. Pipeline Products by Equipment Type
HistoRx, Inc. Pipeline Products by Development Stage
HistoRx, Inc. Pipeline Products by Therapy Area

Future Pharmaceuticals
Matritech, Inc.
LAMPIRE Biological Laboratories, Inc.
Advion BioSciences, Inc.
Dominion Diagnostics, LLC
Cenetron Diagnostics Ltd
Sound Medical Imaging

Customers who bought this item also bought